Close
Digital Health & Ai Innovation summit 2026
APE 2026

John Snow Labs Announces State-of-the-Art Enhancements to its Spark NLP Technology, Resulting in 2.5M Downloads and 9x Growth in 2020

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Supplier Quality Management in Complex Pharma...

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

John Snow Labs, the AI and NLP for healthcare company and developer of the Spark NLP library, today announced that it has crossed the 2.5 million download mark, experiencing 9x growth of its Spark NLP technology since January 2020. Used by 54% of healthcare organizations, Spark NLP has secured the spot as the world’s most widely used natural language processing (NLP) library in the enterprise, after only four years on the market. This rapid growth can be attributed to a long series of enhancements made to Spark NLP’s state-of-the-art library, which now comes with more than 300 production-grade pre-trained models and pipelines, used by leading healthcare and life sciences companies.

John Snow Labs released 26 new versions of Spark NLP in 2019 and another 26 in 2020, with the most recent being Spark NLP for Healthcare 2.7. The most significant feature in this latest release is Text to SQL, and other upgrades include more accurate entity resolution and clinical named entity recognizers, new PICO classifier for evidence-based medicine, new biomedical named entity recognizers, and new clinical and traffic accident NER models in German. These models are pre-trained with clinical BioBERT based embeddings, the most powerful contextual language model in the clinical domain today, making it an easy-to-use, best-in-class solution for healthcare NLP projects.

This news comes on the heels of John Snow Labs’ release of its new named entity recognition (NER) model and classifier for Adverse Drug Events (ADE), announced in October. While the ADE NER model helps extract ADE and drug entities from a given text, the new ADE Classifier is trained on various ADE datasets, including academic texts, social media, and clinical notes. By combining ADE NER and Classifier, pre-trained pipelines are already fitted using certain annotators and transformers according to various use cases, saving users from building it from scratch.

“The enhancements to Spark NLP for Healthcare beat state-of-the-art benchmarks in relation extraction, named entity recognition, and adverse event detection, and are successfully being used now by leading healthcare and life science companies,” said David Talby, CTO at John Snow Labs. “We are humbled by the rapid growth of our community, and expect to continue on this trajectory as we improve our NLP technology even further in the new year.”

Not only is John Snow Labs committed to improving how companies from Kaiser Permanente to Roche realize the value of AI and NLP, but also providing education and resources to help further NLP knowledge and adoption. In addition to hosting the first-ever NLP Summit in October, the company, in partnership with Gradient Flow, issued new research exploring the state of NLP in 2020. The research found that Spark NLP was cited as the most popular NLP library across all industries, with more than half of healthcare-affiliated respondents indicating this is what their organization currently uses. In response to this, John Snow Labs will host the first NLP for Healthcare Summit, being held from April 6-9.

To learn more about Spark NLP for Healthcare, or start your free trial, visit: https://www.johnsnowlabs.com/spark-nlp-health/.

About John Snow Labs

John Snow Labs, the AI and NLP for healthcare company, provides state-of-the-art software, models, and data to help healthcare and life science organizations

build, deploy, and operate AI projects. Developer of Spark NLP, the world’s most widely used NLP library in the enterprise, John Snow Labs’ award-winning clinical NLP software powers leading healthcare and pharmaceutical companies including Kaiser Permanente, McKesson, Merck, and Roche. The company is the creator and host of The NLP Summit, further educating and advancing the NLP community.

Latest stories

Related stories

Supplier Quality Management in Complex Pharma Networks

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Advancing Data Integrity Across Biotech Manufacturing

Ensuring the accuracy and reliability of information is the lifeblood of biotechnology production, where even minor discrepancies in digital or physical records can compromise product safety and regulatory standing.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »